Multiple Malignant Lymphomas of the Bile Duct Developing after Spontaneous Regression of an Autoimmune Pancreatitis-like Mass

We herein report a 67-year-old woman with malignant lymphomas of the bile duct that developed after regression of a pancreatic head mass. Computed tomography suggested the mass was pancreatic head cancer. Endoscopic ultrasonography showed a low-echoic mass with hyperechoic strands resembling autoimm...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Internal Medicine 2021/02/01, Vol.60(3), pp.409-415
Hauptverfasser: Ohtsubo, Koushiro, Yamashita, Kaname, Yanagimura, Naohiro, Suzuki, Chiaki, Tanimoto, Azusa, Nishiyama, Akihiro, Takeuchi, Shinji, Iwaki, Noriko, Kawano, Mitsuhiro, Izumozaki, Akira, Inoue, Dai, Gabata, Toshifumi, Ikeda, Hiroko, Watanabe, Michio, Yano, Seiji
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 415
container_issue 3
container_start_page 409
container_title Internal Medicine
container_volume 60
creator Ohtsubo, Koushiro
Yamashita, Kaname
Yanagimura, Naohiro
Suzuki, Chiaki
Tanimoto, Azusa
Nishiyama, Akihiro
Takeuchi, Shinji
Iwaki, Noriko
Kawano, Mitsuhiro
Izumozaki, Akira
Inoue, Dai
Gabata, Toshifumi
Ikeda, Hiroko
Watanabe, Michio
Yano, Seiji
description We herein report a 67-year-old woman with malignant lymphomas of the bile duct that developed after regression of a pancreatic head mass. Computed tomography suggested the mass was pancreatic head cancer. Endoscopic ultrasonography showed a low-echoic mass with hyperechoic strands resembling autoimmune pancreatitis. Her serum IgG4 concentration was elevated to 674 mg/dL. After the pancreatic head mass spontaneously diminished, three masses were detected in the common bile duct. A biopsy of the major papilla revealed high-grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangement. Systemic chemotherapy with rituximab plus etoposide, prednisolone, vincristine, cyclophosphamide and doxorubicin resulted in complete remission.
doi_str_mv 10.2169/internalmedicine.5429-20
format Article
fullrecord <record><control><sourceid>proquest_pubme</sourceid><recordid>TN_cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7925286</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2438993236</sourcerecordid><originalsourceid>FETCH-LOGICAL-c666t-259afa0269be1c0078c4c1f6298a67b1022bc1d6fff7eb26962e97d4b23a133b3</originalsourceid><addsrcrecordid>eNplkctu1DAUhi0EosPAKyBLbNik-JI48QaptNykKSAua8vxnGQ8OHZqO5W64N1JNMMIyuacxfnO7f8RwpScMyrkK-szRK_dAFtrrIfzqmSyYOQBWlFeyqJmvHqIVkTSpmBzOENPUtoTwptassfojLNGcC6qFfp1PblsRwf4Wjvbe-0z3twN4y4MOuHQ4bwD_MbO9avJZHwFt-DCaH2PdTffgL-NwWftIUwJf4U-Qko2-KVRe3wx5WCHYfKAv2hvIuhss02Fsz-XfSk9RY867RI8O-Y1-vHu7ffLD8Xm8_uPlxebwgghcsEqqTtNmJAtUENI3ZjS0E4w2WhRt5Qw1hq6FV3X1dDOmGAg623ZMq4p5y1fo9eHuePUzpoZ8Dlqp8ZoBx3vVNBW_Vvxdqf6cKtmuapFqzV6eRwQw80EKavBJgPOHV5XrOSNlJzxBX1xD92HaTFroRpBG8JoM1PNgTIxpBShOx1DiVo8Vvc9VovHipG59fnfz5wa_5g6A58OwD5l3cMJ0DFb4-D_yYIovoTjhhNodjoq8Pw3rcXH-Q</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2486180218</pqid></control><display><type>article</type><title>Multiple Malignant Lymphomas of the Bile Duct Developing after Spontaneous Regression of an Autoimmune Pancreatitis-like Mass</title><source>MEDLINE</source><source>PubMed Central Open Access</source><source>J-STAGE (Japan Science &amp; Technology Information Aggregator, Electronic) Freely Available Titles - Japanese</source><source>PubMed Central</source><creator>Ohtsubo, Koushiro ; Yamashita, Kaname ; Yanagimura, Naohiro ; Suzuki, Chiaki ; Tanimoto, Azusa ; Nishiyama, Akihiro ; Takeuchi, Shinji ; Iwaki, Noriko ; Kawano, Mitsuhiro ; Izumozaki, Akira ; Inoue, Dai ; Gabata, Toshifumi ; Ikeda, Hiroko ; Watanabe, Michio ; Yano, Seiji</creator><creatorcontrib>Ohtsubo, Koushiro ; Yamashita, Kaname ; Yanagimura, Naohiro ; Suzuki, Chiaki ; Tanimoto, Azusa ; Nishiyama, Akihiro ; Takeuchi, Shinji ; Iwaki, Noriko ; Kawano, Mitsuhiro ; Izumozaki, Akira ; Inoue, Dai ; Gabata, Toshifumi ; Ikeda, Hiroko ; Watanabe, Michio ; Yano, Seiji</creatorcontrib><description>We herein report a 67-year-old woman with malignant lymphomas of the bile duct that developed after regression of a pancreatic head mass. Computed tomography suggested the mass was pancreatic head cancer. Endoscopic ultrasonography showed a low-echoic mass with hyperechoic strands resembling autoimmune pancreatitis. Her serum IgG4 concentration was elevated to 674 mg/dL. After the pancreatic head mass spontaneously diminished, three masses were detected in the common bile duct. A biopsy of the major papilla revealed high-grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangement. Systemic chemotherapy with rituximab plus etoposide, prednisolone, vincristine, cyclophosphamide and doxorubicin resulted in complete remission.</description><identifier>ISSN: 0918-2918</identifier><identifier>EISSN: 1349-7235</identifier><identifier>DOI: 10.2169/internalmedicine.5429-20</identifier><identifier>PMID: 32863365</identifier><language>eng</language><publisher>Japan: The Japanese Society of Internal Medicine</publisher><subject>Aged ; Antineoplastic Combined Chemotherapy Protocols - therapeutic use ; Autoimmune Pancreatitis ; automiine pancreatitis ; B-cell lymphoma ; Bcl-6 protein ; Beta cells ; Bile ; bile duct ; Bile Ducts ; Biopsy ; Case Report ; Chemotherapy ; Computed tomography ; Cyclophosphamide ; Doxorubicin ; Etoposide ; Female ; high-grade B-cell lymphoma ; Humans ; IgG4-related disease ; Immunoglobulin G ; Internal medicine ; Lymphoma ; Lymphoma, Large B-Cell, Diffuse - drug therapy ; Monoclonal antibodies ; Myc protein ; non-Hodgkin lymphoma ; Pancreas ; Pancreatic cancer ; Pancreatitis ; Prednisolone ; Prednisone - therapeutic use ; Proto-Oncogene Proteins c-bcl-2 - therapeutic use ; Proto-Oncogene Proteins c-bcl-6 ; Remission ; Rituximab ; Targeted cancer therapy ; Vincristine ; with MYC and BCL2 and/or BCL6 rearrangements</subject><ispartof>Internal Medicine, 2021/02/01, Vol.60(3), pp.409-415</ispartof><rights>2021 by The Japanese Society of Internal Medicine</rights><rights>Copyright Japan Science and Technology Agency 2021</rights><rights>Copyright © 2021 by The Japanese Society of Internal Medicine</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c666t-259afa0269be1c0078c4c1f6298a67b1022bc1d6fff7eb26962e97d4b23a133b3</citedby><cites>FETCH-LOGICAL-c666t-259afa0269be1c0078c4c1f6298a67b1022bc1d6fff7eb26962e97d4b23a133b3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925286/pdf/$$EPDF$$P50$$Gpubmedcentral$$Hfree_for_read</linktopdf><linktohtml>$$Uhttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC7925286/$$EHTML$$P50$$Gpubmedcentral$$Hfree_for_read</linktohtml><link.rule.ids>230,314,725,778,782,883,1879,27911,27912,53778,53780</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/32863365$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Ohtsubo, Koushiro</creatorcontrib><creatorcontrib>Yamashita, Kaname</creatorcontrib><creatorcontrib>Yanagimura, Naohiro</creatorcontrib><creatorcontrib>Suzuki, Chiaki</creatorcontrib><creatorcontrib>Tanimoto, Azusa</creatorcontrib><creatorcontrib>Nishiyama, Akihiro</creatorcontrib><creatorcontrib>Takeuchi, Shinji</creatorcontrib><creatorcontrib>Iwaki, Noriko</creatorcontrib><creatorcontrib>Kawano, Mitsuhiro</creatorcontrib><creatorcontrib>Izumozaki, Akira</creatorcontrib><creatorcontrib>Inoue, Dai</creatorcontrib><creatorcontrib>Gabata, Toshifumi</creatorcontrib><creatorcontrib>Ikeda, Hiroko</creatorcontrib><creatorcontrib>Watanabe, Michio</creatorcontrib><creatorcontrib>Yano, Seiji</creatorcontrib><title>Multiple Malignant Lymphomas of the Bile Duct Developing after Spontaneous Regression of an Autoimmune Pancreatitis-like Mass</title><title>Internal Medicine</title><addtitle>Intern. Med.</addtitle><description>We herein report a 67-year-old woman with malignant lymphomas of the bile duct that developed after regression of a pancreatic head mass. Computed tomography suggested the mass was pancreatic head cancer. Endoscopic ultrasonography showed a low-echoic mass with hyperechoic strands resembling autoimmune pancreatitis. Her serum IgG4 concentration was elevated to 674 mg/dL. After the pancreatic head mass spontaneously diminished, three masses were detected in the common bile duct. A biopsy of the major papilla revealed high-grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangement. Systemic chemotherapy with rituximab plus etoposide, prednisolone, vincristine, cyclophosphamide and doxorubicin resulted in complete remission.</description><subject>Aged</subject><subject>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</subject><subject>Autoimmune Pancreatitis</subject><subject>automiine pancreatitis</subject><subject>B-cell lymphoma</subject><subject>Bcl-6 protein</subject><subject>Beta cells</subject><subject>Bile</subject><subject>bile duct</subject><subject>Bile Ducts</subject><subject>Biopsy</subject><subject>Case Report</subject><subject>Chemotherapy</subject><subject>Computed tomography</subject><subject>Cyclophosphamide</subject><subject>Doxorubicin</subject><subject>Etoposide</subject><subject>Female</subject><subject>high-grade B-cell lymphoma</subject><subject>Humans</subject><subject>IgG4-related disease</subject><subject>Immunoglobulin G</subject><subject>Internal medicine</subject><subject>Lymphoma</subject><subject>Lymphoma, Large B-Cell, Diffuse - drug therapy</subject><subject>Monoclonal antibodies</subject><subject>Myc protein</subject><subject>non-Hodgkin lymphoma</subject><subject>Pancreas</subject><subject>Pancreatic cancer</subject><subject>Pancreatitis</subject><subject>Prednisolone</subject><subject>Prednisone - therapeutic use</subject><subject>Proto-Oncogene Proteins c-bcl-2 - therapeutic use</subject><subject>Proto-Oncogene Proteins c-bcl-6</subject><subject>Remission</subject><subject>Rituximab</subject><subject>Targeted cancer therapy</subject><subject>Vincristine</subject><subject>with MYC and BCL2 and/or BCL6 rearrangements</subject><issn>0918-2918</issn><issn>1349-7235</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2021</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNplkctu1DAUhi0EosPAKyBLbNik-JI48QaptNykKSAua8vxnGQ8OHZqO5W64N1JNMMIyuacxfnO7f8RwpScMyrkK-szRK_dAFtrrIfzqmSyYOQBWlFeyqJmvHqIVkTSpmBzOENPUtoTwptassfojLNGcC6qFfp1PblsRwf4Wjvbe-0z3twN4y4MOuHQ4bwD_MbO9avJZHwFt-DCaH2PdTffgL-NwWftIUwJf4U-Qko2-KVRe3wx5WCHYfKAv2hvIuhss02Fsz-XfSk9RY867RI8O-Y1-vHu7ffLD8Xm8_uPlxebwgghcsEqqTtNmJAtUENI3ZjS0E4w2WhRt5Qw1hq6FV3X1dDOmGAg623ZMq4p5y1fo9eHuePUzpoZ8Dlqp8ZoBx3vVNBW_Vvxdqf6cKtmuapFqzV6eRwQw80EKavBJgPOHV5XrOSNlJzxBX1xD92HaTFroRpBG8JoM1PNgTIxpBShOx1DiVo8Vvc9VovHipG59fnfz5wa_5g6A58OwD5l3cMJ0DFb4-D_yYIovoTjhhNodjoq8Pw3rcXH-Q</recordid><startdate>20210201</startdate><enddate>20210201</enddate><creator>Ohtsubo, Koushiro</creator><creator>Yamashita, Kaname</creator><creator>Yanagimura, Naohiro</creator><creator>Suzuki, Chiaki</creator><creator>Tanimoto, Azusa</creator><creator>Nishiyama, Akihiro</creator><creator>Takeuchi, Shinji</creator><creator>Iwaki, Noriko</creator><creator>Kawano, Mitsuhiro</creator><creator>Izumozaki, Akira</creator><creator>Inoue, Dai</creator><creator>Gabata, Toshifumi</creator><creator>Ikeda, Hiroko</creator><creator>Watanabe, Michio</creator><creator>Yano, Seiji</creator><general>The Japanese Society of Internal Medicine</general><general>Japan Science and Technology Agency</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7T5</scope><scope>7TK</scope><scope>7U9</scope><scope>H94</scope><scope>7X8</scope><scope>5PM</scope></search><sort><creationdate>20210201</creationdate><title>Multiple Malignant Lymphomas of the Bile Duct Developing after Spontaneous Regression of an Autoimmune Pancreatitis-like Mass</title><author>Ohtsubo, Koushiro ; Yamashita, Kaname ; Yanagimura, Naohiro ; Suzuki, Chiaki ; Tanimoto, Azusa ; Nishiyama, Akihiro ; Takeuchi, Shinji ; Iwaki, Noriko ; Kawano, Mitsuhiro ; Izumozaki, Akira ; Inoue, Dai ; Gabata, Toshifumi ; Ikeda, Hiroko ; Watanabe, Michio ; Yano, Seiji</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c666t-259afa0269be1c0078c4c1f6298a67b1022bc1d6fff7eb26962e97d4b23a133b3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2021</creationdate><topic>Aged</topic><topic>Antineoplastic Combined Chemotherapy Protocols - therapeutic use</topic><topic>Autoimmune Pancreatitis</topic><topic>automiine pancreatitis</topic><topic>B-cell lymphoma</topic><topic>Bcl-6 protein</topic><topic>Beta cells</topic><topic>Bile</topic><topic>bile duct</topic><topic>Bile Ducts</topic><topic>Biopsy</topic><topic>Case Report</topic><topic>Chemotherapy</topic><topic>Computed tomography</topic><topic>Cyclophosphamide</topic><topic>Doxorubicin</topic><topic>Etoposide</topic><topic>Female</topic><topic>high-grade B-cell lymphoma</topic><topic>Humans</topic><topic>IgG4-related disease</topic><topic>Immunoglobulin G</topic><topic>Internal medicine</topic><topic>Lymphoma</topic><topic>Lymphoma, Large B-Cell, Diffuse - drug therapy</topic><topic>Monoclonal antibodies</topic><topic>Myc protein</topic><topic>non-Hodgkin lymphoma</topic><topic>Pancreas</topic><topic>Pancreatic cancer</topic><topic>Pancreatitis</topic><topic>Prednisolone</topic><topic>Prednisone - therapeutic use</topic><topic>Proto-Oncogene Proteins c-bcl-2 - therapeutic use</topic><topic>Proto-Oncogene Proteins c-bcl-6</topic><topic>Remission</topic><topic>Rituximab</topic><topic>Targeted cancer therapy</topic><topic>Vincristine</topic><topic>with MYC and BCL2 and/or BCL6 rearrangements</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Ohtsubo, Koushiro</creatorcontrib><creatorcontrib>Yamashita, Kaname</creatorcontrib><creatorcontrib>Yanagimura, Naohiro</creatorcontrib><creatorcontrib>Suzuki, Chiaki</creatorcontrib><creatorcontrib>Tanimoto, Azusa</creatorcontrib><creatorcontrib>Nishiyama, Akihiro</creatorcontrib><creatorcontrib>Takeuchi, Shinji</creatorcontrib><creatorcontrib>Iwaki, Noriko</creatorcontrib><creatorcontrib>Kawano, Mitsuhiro</creatorcontrib><creatorcontrib>Izumozaki, Akira</creatorcontrib><creatorcontrib>Inoue, Dai</creatorcontrib><creatorcontrib>Gabata, Toshifumi</creatorcontrib><creatorcontrib>Ikeda, Hiroko</creatorcontrib><creatorcontrib>Watanabe, Michio</creatorcontrib><creatorcontrib>Yano, Seiji</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Immunology Abstracts</collection><collection>Neurosciences Abstracts</collection><collection>Virology and AIDS Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><collection>PubMed Central (Full Participant titles)</collection><jtitle>Internal Medicine</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Ohtsubo, Koushiro</au><au>Yamashita, Kaname</au><au>Yanagimura, Naohiro</au><au>Suzuki, Chiaki</au><au>Tanimoto, Azusa</au><au>Nishiyama, Akihiro</au><au>Takeuchi, Shinji</au><au>Iwaki, Noriko</au><au>Kawano, Mitsuhiro</au><au>Izumozaki, Akira</au><au>Inoue, Dai</au><au>Gabata, Toshifumi</au><au>Ikeda, Hiroko</au><au>Watanabe, Michio</au><au>Yano, Seiji</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Multiple Malignant Lymphomas of the Bile Duct Developing after Spontaneous Regression of an Autoimmune Pancreatitis-like Mass</atitle><jtitle>Internal Medicine</jtitle><addtitle>Intern. Med.</addtitle><date>2021-02-01</date><risdate>2021</risdate><volume>60</volume><issue>3</issue><spage>409</spage><epage>415</epage><pages>409-415</pages><issn>0918-2918</issn><eissn>1349-7235</eissn><abstract>We herein report a 67-year-old woman with malignant lymphomas of the bile duct that developed after regression of a pancreatic head mass. Computed tomography suggested the mass was pancreatic head cancer. Endoscopic ultrasonography showed a low-echoic mass with hyperechoic strands resembling autoimmune pancreatitis. Her serum IgG4 concentration was elevated to 674 mg/dL. After the pancreatic head mass spontaneously diminished, three masses were detected in the common bile duct. A biopsy of the major papilla revealed high-grade B-cell lymphoma with MYC, BCL2 and/or BCL6 rearrangement. Systemic chemotherapy with rituximab plus etoposide, prednisolone, vincristine, cyclophosphamide and doxorubicin resulted in complete remission.</abstract><cop>Japan</cop><pub>The Japanese Society of Internal Medicine</pub><pmid>32863365</pmid><doi>10.2169/internalmedicine.5429-20</doi><tpages>7</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0918-2918
ispartof Internal Medicine, 2021/02/01, Vol.60(3), pp.409-415
issn 0918-2918
1349-7235
language eng
recordid cdi_pubmedcentral_primary_oai_pubmedcentral_nih_gov_7925286
source MEDLINE; PubMed Central Open Access; J-STAGE (Japan Science & Technology Information Aggregator, Electronic) Freely Available Titles - Japanese; PubMed Central
subjects Aged
Antineoplastic Combined Chemotherapy Protocols - therapeutic use
Autoimmune Pancreatitis
automiine pancreatitis
B-cell lymphoma
Bcl-6 protein
Beta cells
Bile
bile duct
Bile Ducts
Biopsy
Case Report
Chemotherapy
Computed tomography
Cyclophosphamide
Doxorubicin
Etoposide
Female
high-grade B-cell lymphoma
Humans
IgG4-related disease
Immunoglobulin G
Internal medicine
Lymphoma
Lymphoma, Large B-Cell, Diffuse - drug therapy
Monoclonal antibodies
Myc protein
non-Hodgkin lymphoma
Pancreas
Pancreatic cancer
Pancreatitis
Prednisolone
Prednisone - therapeutic use
Proto-Oncogene Proteins c-bcl-2 - therapeutic use
Proto-Oncogene Proteins c-bcl-6
Remission
Rituximab
Targeted cancer therapy
Vincristine
with MYC and BCL2 and/or BCL6 rearrangements
title Multiple Malignant Lymphomas of the Bile Duct Developing after Spontaneous Regression of an Autoimmune Pancreatitis-like Mass
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-15T12%3A00%3A49IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_pubme&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Multiple%20Malignant%20Lymphomas%20of%20the%20Bile%20Duct%20Developing%20after%20Spontaneous%20Regression%20of%20an%20Autoimmune%20Pancreatitis-like%20Mass&rft.jtitle=Internal%20Medicine&rft.au=Ohtsubo,%20Koushiro&rft.date=2021-02-01&rft.volume=60&rft.issue=3&rft.spage=409&rft.epage=415&rft.pages=409-415&rft.issn=0918-2918&rft.eissn=1349-7235&rft_id=info:doi/10.2169/internalmedicine.5429-20&rft_dat=%3Cproquest_pubme%3E2438993236%3C/proquest_pubme%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2486180218&rft_id=info:pmid/32863365&rfr_iscdi=true